Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of dexmedetomidine compared to midazolam to reduce delirium in critically ill children on breathing machines in intensive care

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • Cannabidiol for behavioral problems in patients with Tuberous Sclerosis Complex, Sanfilippo syndrome, and Fragile X syndrome

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    The Netherlands
  • Study comparing amoxicillin/clavulanic acid treatment versus surgery for children with uncomplicated appendicitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Comparison of two concentrations of levobupivacaine (0.

    Not yet recruiting

    3 1 1 1
    Spain
  • Study comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Germany Italy Spain
  • Safety and early effectiveness study of VG801 subretinal injection in patients with ABCA4 mutation-associated retinal dystrophy

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Germany
  • Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

    Not yet recruiting

    2 1 1 1
    Austria Belgium Denmark France Germany Italy +3
  • Study of Anakinra compared to placebo for treating acute myocarditis in children admitted to intensive care units

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of cannabidiol to reduce self-injurious behavior in children and adolescents with severe neurodevelopmental disorders

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    France
  • First study of TTX-381 gene therapy safety in patients with eye problems caused by CLN2 disease (Neuronal Ceroid Lipofuscinosis Type 2)

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Germany